Whole-exome mutational landscape and molecular marker study in mucinous and clear cell ovarian cancer cell lines 3AO and ES2
Open Access
- 6 April 2023
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 23 (1) , 1-13
Abstract
Background: Ovarian cancer is one of the most lethal cancers in women because it is often diagnosed at an advanced stage. The molecular markers investigated thus far have been unsatisfactory. Methods: We performed whole-exome sequencing on the human ovarian cancer cell lines 3AO and ES2 and the normal ovarian epithelial cell line IOSE-80. Molecular markers of ovarian cancer were screened from shared mutation genes and copy number variation genes in the 6q21-qter region. Results: We found that missense mutations were the most common mutations in the gene (93%). The MUC12, FLG and MUC16 genes were highly mutated in 3AO and ES2 cells. Copy number amplification occurred mainly in 4p16.1 and 11q14.3, and copy number deletions occurred in 4q34.3 and 18p11.21. A total of 23 hub genes were screened, of which 16 were closely related to the survival of ovarian cancer patients. The three genes CCDC170, THBS2 and COL14A1 are most significantly correlated with the survival and prognosis of ovarian cancer. In particular, the overall survival of ovarian cancer patients with high CCDC170 gene expression was significantly prolonged (P < 0.001). The expression of CCDC170 in normal tissues was significantly higher than that in ovarian cancer tissues (P < 0.05), and its expression was significantly decreased in advanced ovarian cancer. Western blotting and immunofluorescence assays also showed that the expression of CCDC170 in ovarian cancer cells was significantly lower than that in normal cells (P < 0.001, P < 0.01). Conclusions: CCDC170 is expected to become a new diagnostic molecular target and prognostic indicator for ovarian cancer patients, which can provide new ideas for the design of antitumor drugs.Keywords
Funding Information
- Medical and Health Technology Project of Shenzhen Longgang District (LGKCYLWS2021000023, LGKCYLWS2021000023, LGKCYLWS2021000023, LGKCYLWS2021000023)
- the “ovarian cancer chromosome instability region molecular marker target and clinical application research” enterprise horizontal project
- National Natural Science Foundation of China (81102753)
This publication has 58 references indexed in Scilit:
- Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort ConsortiumJournal of Clinical Oncology, 2016
- Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancerCochrane Database of Systematic Reviews, 2016
- C-terminus of MUC16 activates Wnt signaling pathway through its interaction with β-catenin to promote tumorigenesis and metastasisOncotarget, 2016
- CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA SequencingPLOS Computational Biology, 2016
- A Genome Wide Study of Copy Number Variation Associated with Nasopharyngeal Carcinoma in Malaysian Chinese Identifies CNVs at 11q14.3 and 6p21.3 as Candidate LociPLOS ONE, 2016
- Deletion at 6q24.2–26 predicts longer survival of high‐grade serous epithelial ovarian cancer patientsMolecular Oncology, 2014
- Parkin Gene Alterations in Ovarian Carcinoma from Northern Indian PopulationPathology and Oncology Research, 2011
- Fast and accurate long-read alignment with Burrows–Wheeler transformBioinformatics, 2010
- Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (Review)Oncology Reports, 2009
- An automated method for finding molecular complexes in large protein interaction networksBMC Bioinformatics, 2003